|


Coronary CTA Using SnapShot Pulse on Patient with History of Kawasaki Disease
James Earls, M.D.
Fairfax Radiological Consultants, PC.
Fairfax, Virginia
|
|
Patient history
|
This 19-year-old was originally diagnosed with Kawasaki
disease at age 7. He has been followed serially with
echocardiography and thallium myocardial perfusion exams
because of known bilateral coronary artery aneurysms.
He has done well clinically and was referred for coronary
CTA to evaluate the size of his aneurysms and to evaluate for
possible coronary stenoses. His last prior coronary
angiogram was 11 years ago at age 8.
Kawasaki disease affects the mucous membranes, lymph
nodes, walls of the blood vessels, and the heart. It is an
inflammatory vasculitis, and may be autoimmune in origin.
This vasculitis can be especially dangerous when it damages
the heart’s coronary arteries, causing an abnormal dilation
or aneurysm formation in these vessels. In rare cases,
arterial damage related to Kawasaki syndrome can
significantly interfere with the heart’s blood supply, even to
the point of causing heart failure, myocardial ischemia, and
sudden death.
|
Patient physiological data>
-
Average HR: 63 bpm
-
Height: 5' 10''
-
Weight: 190 lbs
-
BMI: 27
|
Acquisition protocol
-
Scanner: LightSpeed® VCT XT
-
Scan type: Cardiac SnapShot™ Pulse
-
Rotation speed: 0.35 second
-
Detector configuration: 64 x 0.625 mm
-
Slice thickness: 0.625 mm
-
kVp: 120
-
mA: 525
-
Total X-ray exposure time: 1.1 seconds
-
Total scan time: 5 seconds
-
Total radiation dose: 2.35 mSv*
|
Contrast injection parameters
-
Contrast – 80 ml at 5.5 cc/second (15 second duration) 0 second phase delay
-
Saline – 50 ml at 5.5 cc/second (9 second duration)
|
Diagnosis
|
Clinical findings
The coronary CTA exam images helped the radiologist
determine the following:
There is a focal aneurysm involving the distal left main
coronary artery extending into the LAD. This aneurysm is
25 mm in length and is 11 mm in diameter (Figure 1).
There is some circumferential calcification which is relatively
thin. The origin of the left main from the aorta is slightly
prominent, measuring 7 mm.
There is mild narrowing at the origin of the LAD from the
aneurysm itself, measuring 2.4 mm in diameter. Distal to
this, the vessel becomes slightly prominent, measuring up
to 6 mm in diameter before eventually tapering off.
The left circumflex also arises from the aneurismal sac, with
mild to moderate relative narrowing at its origin. One of the
proximal marginal branches also arises from the aneurysm
sac and again there is mild narrowing of its origin identified.
A focal aneurysm of the RCA is identified, again involving the
very proximal RCA. The origin is only minimally prominent at
4 mm, the maximal diameter of the aneurysm is 9 mm and
it is approximately 11 mm in length (Figure 2).
Distal to the aneurysm, the RCA is unremarkable with the
exception of a congenital anomaly of a split distribution
(Figure 3). One portion continues in the A-V groove while a
second portion branches off to feed the interventricular
region.
The PDA arises from the right coronary artery. This vessel
is patent.
Based on the findings, the patient has multiple focal
aneurysms in the left main, LAD, and the proximal RCA.
Also noted is a narrowing of the origin of the LAD from
the aneurysm as well as the first diagonal, marginal and
left circumflex coronary arteries.
|
Discussion
|
It is impressive that the LightSpeed VCT XT is able to pinpoint
these aneurysms and measure them with detailed accuracy.
The images are critical in helping to accurately determine
the current status of the patient’s known heart disease and
will be helpful in following the progression in the future.
Because he remains asymptomatic and no obstructive
disease was depicted, no intervention was required at this
time. br>
The ability to accurately acquire a coronary angiogram in
this case with approximately 2.3 mSv* of effective dose
opens new possibilities for further evaluation. Previously,
this patient has had yearly nuclear myocardial perfusion
exams, which can each approach 50 mSv of effective dose,
depending on the technique used.
In the future, with the advent of SnapShot Pulse on
LightSpeed VCT XT, the referring cardiologist is considering
performing CCTA every other year, alternating yearly with a
nuclear myocardial perfusion exam.
|
|
|